FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Patient Engagement and Regenerative Medicine Summary

FDA releases the transcript from a 5/6 CBER virtual workshop on patient engagement and regenerative medicine.

Medical Devices

Volpara Health 510(k) for Updated Breast Assessment

FDA clears a Volpara Health 510(k) for the latest version of its key science algorithm, Volpara Imaging Software (VIS 3.2), a breast density assessmen...

Biologics

Genentech BLA for Faricimab for Eye Disorders

FDA accepts for a priority review a Genentech BLA for faricimab for treating wet, or neovascular, age-related macular degeneration and diabetic macula...

Medical Devices

Many Reports of Medical Device Deaths Misclassified: Study

Researchers say many reporters to the FDA MAUDE medical device database misclassify deaths in other categories.

Biologics

FDA OKs Emergent Resumption of Vaccine Production

FDA says Emergent BioSolutions can resume producing J&J Covid-19 vaccine at its Bayview manufacturing facility.

Human Drugs

FDA Approves Mylan Semglee Biosimilar Insulin Product

FDA approves Mylans Semglee, the first biosimilar and interchangeable insulin product approved in the U.S.

Federal Register

Ceclor Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Eli Lillys Ceclor CD (cefaclor extended-release tablets) 375 mg and 500 mg were not withdrawn from sale f...

Human Drugs

ICH Drug Continuous Mfg. Guidance Open for Comment

The International Council for Harmonization says its Q13 guidance on drug continuous manufacturing is available for public comment.

Federal Register

FY 2022 Generic Drug User Fee Rates

Federal Register notice: FDA announces the generic drug user fee rates for fiscal year FY 2022.

Federal Register

Debarment Order Against Justin Ash

Federal Register notice: FDA issues a five-year debarment order against Justin Ash due to his felony conviction for illegal importation of a drug or c...